TrialDiabetes, obesity & metabolism2019

Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.

Elizabeth Selvin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.